(Q40934118)

25 September 2017

title

A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia (English)

1 reference

25 September 2017

0 references

1 reference

2

Drexler HG

1 reference

25 September 2017

Matsuo Y

1

1 reference

25 September 2017

Takeuchi M

series ordinal

3

1 reference

25 September 2017

Orita K

series ordinal

4

1 reference

25 September 2017

publication date

1 August 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

23

1 reference

25 September 2017

issue

8

1 reference

25 September 2017

page(s)

731-740

1 reference

describes a project that uses

25 September 2017

NALM-29

0 references

cites work

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Acute lymphoblastic leukemia with myeloperoxidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Establishment and characterization of human B cell precursor-leukemia cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

A Non-T, Non-B Human Leukemia Cell Line (NALM-1): Establishment of the Cell Line and Presence of Leukemia-Associated Antigens2

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

A Philadelphia chromosome positive human leukaemia cell line (NALM-1) with pre-B characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Leukemia cell lines: in vitro models for the study of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Preparation and characterization of monoclonal antibodies against human myeloperoxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

A rapid banding technique for human chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2899%2900086-7

7 January 2021

10.1016/S0145-2126(99)00086-7

Identifiers

DOI

1 reference

25 September 2017

1 reference